-
A remedy that enhances the effect of another therapy.
adjuvant
-
A remedy that replaces a patient’s blood or bone marrow with blood or bone marrow from a donor
allogeneic
-
The loss of hair.
alopecia
-
The establishment of blood supply through formation of new blood vessels.
angiogenesis
-
A drug that prevents, kills, or blocks the growth and spread of cancer cells.
antineoplastic
-
The collection and storage of blood or blood components from a patient for subsequent transfusion to that same person.
autologous
-
The treatment with radioactive sources placed into or near the tumor or affected area
brachytherapy
-
A breakdown of muscle mass resulting from rapid weight loss or a general wasting due to illness or stress.
cachexia
-
The separation of a wound or scar. A rupture or splitting open, as of a surgical wound or of an organ or structure to discharge its contents as splitting open
dehiscence
-
Relating to the formation of red blood cells.
erythropoietic
-
An inflammation of the tongue.
glossitis
-
The degree of malignancy or cell differentiation of the tumor cells.
grading
-
A procedure to collect tissue such as the spongy bone marrow from inside bones containing stem cells.
harvesting
-
Pertaining to the formation of blood or blood.
hematopoietic
-
Increase in number.
hyperplasia
-
Abnormal enlargement, increase in size and mass, of a body part or organ.
hypertrophy
-
Within the spinal canal, the space between the double-layered covering or lining of the brain and spinal cord.
intrathecal
-
The removal of blood to collect specific blood cells; the remaining blood is returned to the body
leukapheresis
-
Cells that invade and destroy nearby tissues and spread to other parts of the body
malignant
-
Spread of cancerous tumor to other distant locations.
metastasis
-
An inflammation and ulceration of the lining of the mouth, throat, or gastrointestinal (Gl) tract most commonly associated with chemotherapy or radiotherapy for cancer.
mucositis
-
A decrease in the production of red blood cells, platelets, and some white blood cells by the bone marrow. Also, inhibition of the production of blood cells, a bone marrow function nadir. The period of time following chemotherapy, usually 7 to 10 days after chemotherapy when blood counts drop, thereby increasing susceptibility to infection or bleeding
myelosuppression
-
Adjunctive or adjuvant therapy given prior to the primary (main) therapy.
neoadjuvant
-
An abnormal mass of cells, can be benign or malignant.
neoplasm
-
Cancer susceptibility genes. When altered or mutated proto-oncogenes promote tumor formation or growth.
oncogenes
-
The process of easing symptoms and maximizing quality of life when cure or control is not possible
palliation
-
The use of X-rays and other forms of radiation in treatment.
radiotherapy
-
The extent or spread of the tumor within the body from the site of origin.
staging
-
The inflammation of the soft tissues in the mouth resulting in mouth sores. It is a common side effect of chemotherapy, radiation therapy, and some biological therapy.
stomatitis
-
Substances that are expressed by the tumor or by normal tissue in response to a tumor
tumor markers
-
Inflammatory biochemical that is produced in response to various stressors
tumor necrosis factor
-
An intravenous (IV) medication that causes blisters and tissue injury when it escapes into surrounding tissue. Vesicatory refers to causing blisters
vesicant
|
|